Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-midazolam vs ketamine-dexmedetomidine for hemodynamic changes during fiberoptic bronchoscopy
IRCT20200825048515N13Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in None comparing ketamine + midazolam with ketamine + dexmedetomidine (2 arms). Primary endpoint: Hemodynamic changes during fiberoptic bronchoscopy. Started Oct 2020; status: completed.
02
Drugs
ketaminemidazolamdexmedetomidine
Beyond the preview
Go deeper on IRCT20200825048515N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N13.